Vivek Ramaswamy’s Strive übernimmt Semler Scientific in 675-Millionen-Dollar-Aktiendeal

Fintech trifft Medizintechnik: Strive, die Investmentfirma des Unternehmers Vivek Ramaswamy, schluckt den Gesundheitspionier Semler Scientific.

Der Deal im Detail

Für umgerechnet 675 Millionen Dollar wechselt das Unternehmen den Besitzer – komplett finanziert durch Aktien. Keine Barreserven nötig, nur Beteiligungszertifikate. Typisch für Ramaswamys aggressive Expansionsstrategie.

Was die Übernahme bedeutet

Semler Scientific bringt medizinische Technologie-Expertise in das Portfolio. Strive erhält Zugang zu patentgeschützten Gesundheitslösungen. Die Branche erwartet disruptive Synergien – oder zumindest interessante Quartalszahlen für Aktionäre.

Wall Street reagiert verhalten. Analysten fragen sich, ob dies der nächste geniale Schachzug ist oder einfach nur wieder eine Überbewertung mit Papiergeld. Immerhin: Die 675 Millionen Dollar in Aktien machen die Transaktion steuerlich... interessant.

Transitioning to a preferred-equity model

The post-merger company will use a preferred-equity structure, a MOVE that Strive executives say will mitigate the risks of traditional debt financing. The preferred equity structure is designed to accelerate Bitcoin accumulation while lowering the potential volatility of debt maturities. 

According to Strive CEO Matt Cole, this merger makes the firm the dominant Bitcoin treasury company, one with a plan to far outpace the growth rate of Bitcoin itself in terms of per-share value.

 “This merger cements Strive’s position as a top Bitcoin treasury company, and we believe our alpha-seeking strategies and capital structure position us to outperform Bitcoin over the long run.”

Matt Cole

Before its announcement of hoarding Bitcoin, Strive was recognized as an asset-management enterprise – it operates several exchange-traded funds, such as the $1 billion Strive 500 ETF (ticker STRV) that tracks the largest US companies.

Bitcoin’s role in corporate balance sheets and its price outlook

The Strive decision to increase its Bitcoin holdings is one of the greatest trends of companies integrating Bitcoin into their financial strategies. Semler Scientific, a medical device manufacturer, previously made headlines by declaring Bitcoin as its main treasury reserve, after Michael Saylor, founder of Strategy, Inc., did the same. 

Strategy is the world’s largest corporate holder of Bitcoin, with over 639,000 BTC acquired at an average of $73,971 per coin. Just today, Strategy purchased 850 BTC, as reported by Cryptopolitan. Bitcoin is currently trading at $112,940.64, registering a 5% decline in the past 24 hours. 

The cryptocurrency swung between $111,986 and $115,776 throughout the day, suggesting increased volatility and key technical signs on various timeframes. Bitcoin had a solid week, going up from below $115,000 to a monthly high of $118,000 on Thursday morning, just after the U.S. Federal Reserve cut interest rates. While this move was largely anticipated, it still generated short-lived, slight gains for BTC.

However, the cryptocurrency failed to maintain its momentum and fell back to $115,000 by Friday. Over the weekend, the stock traded sideways between $115,000 and $116,000, with a rejection at the high end on Saturday night. However, Bitcoin maintained the $115,500 support level on Sunday. Despite the recent dip, Bitcoin is still up 5% for September due to improving liquidity conditions.

Get seen where it counts. Advertise in Cryptopolitan Research and reach crypto’s sharpest investors and builders.